WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 71.00
-1.00 (-1.39%)
Jun 18, 2026, 10:50 AM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.23 billion as of June 18, 2026. Its market cap has increased by 22.20% in one year.
Market Cap
3.23B
Enterprise Value
3.80B
Revenue
1.14B
Ranking
n/a
PE Ratio
15.36
Stock Price
71.00
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.23B, a decrease of -5.87%. That is a compound annual growth rate of -2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.23B | -3.27% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 6.38B |
| Hi-Clearance | 5.83B |
| Bonraybio | 3.30B |
| Applied BioCode | 2.51B |
| A Plus Biotechnology | 2.48B |
| Medimaging Integrated Solution | 2.41B |
| Wellell | 2.36B |
| OK Biotech | 2.16B |